JP2021525738A5 - - Google Patents

Info

Publication number
JP2021525738A5
JP2021525738A5 JP2020566706A JP2020566706A JP2021525738A5 JP 2021525738 A5 JP2021525738 A5 JP 2021525738A5 JP 2020566706 A JP2020566706 A JP 2020566706A JP 2020566706 A JP2020566706 A JP 2020566706A JP 2021525738 A5 JP2021525738 A5 JP 2021525738A5
Authority
JP
Japan
Prior art keywords
imidazo
pyrazine
pyrido
bromo
methylpiperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2020566706A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021525738A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2019/006553 external-priority patent/WO2019231270A1/en
Publication of JP2021525738A publication Critical patent/JP2021525738A/ja
Publication of JP2021525738A5 publication Critical patent/JP2021525738A5/ja
Withdrawn legal-status Critical Current

Links

JP2020566706A 2018-05-31 2019-05-31 複素環誘導体及びその使用 Withdrawn JP2021525738A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180062254 2018-05-31
KR10-2018-0062254 2018-05-31
PCT/KR2019/006553 WO2019231270A1 (en) 2018-05-31 2019-05-31 Heterocyclic derivatives and use thereof

Publications (2)

Publication Number Publication Date
JP2021525738A JP2021525738A (ja) 2021-09-27
JP2021525738A5 true JP2021525738A5 (https=) 2022-04-04

Family

ID=68698381

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020566706A Withdrawn JP2021525738A (ja) 2018-05-31 2019-05-31 複素環誘導体及びその使用

Country Status (12)

Country Link
US (1) US20210198259A1 (https=)
EP (1) EP3807282A4 (https=)
JP (1) JP2021525738A (https=)
KR (1) KR102344295B1 (https=)
CN (1) CN112204032A (https=)
AU (1) AU2019279421A1 (https=)
BR (1) BR112020023946A2 (https=)
CA (1) CA3098825A1 (https=)
MX (1) MX2020011955A (https=)
SG (1) SG11202010985TA (https=)
TW (1) TW202021969A (https=)
WO (1) WO2019231270A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021174024A1 (en) 2020-02-28 2021-09-02 First Wave Bio, Inc. Methods of treating iatrogenic autoimmune colitis
US11345681B1 (en) 2020-06-05 2022-05-31 Kinnate Biopharma Inc. Inhibitors of fibroblast growth factor receptor kinases
EP4067357A1 (en) 2021-03-30 2022-10-05 JW Pharmaceutical Corporation Novel crystalline form of 1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-n-methylazetidin-3-amine hydrogen sulfate monohydrate
CN113929634A (zh) * 2021-11-22 2022-01-14 山西永津集团有限公司 一种2,3-二溴喹喔啉的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE358395B (https=) * 1967-09-27 1973-07-30 Siegfried Ag
WO2004085439A1 (en) * 2003-03-27 2004-10-07 Pfizer Products Inc. Substituted 4-amino[1,2,4]triazolo[4,3-a]quinoxalines
AR073574A1 (es) * 2008-09-10 2010-11-17 Alcon Res Ltd Inhibidores heterociclicos de los receptores de histamina para el tratamiento de una enfermedad
TW201204727A (en) * 2010-03-10 2012-02-01 Kalypsys Inc Heterocyclic inhibitors of histamine receptors for the treatment of disease
TW201206936A (en) * 2010-07-19 2012-02-16 Alcon Res Ltd Methods and compositions for the treatment of allergy
RU2628074C2 (ru) * 2011-09-30 2017-08-14 Си энд Си РИСЕРЧ ЛЭБОРЕТРИЗ ТРИЦИКЛИЧЕСКИЕ АЗОТСОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ ИМИДАЗО[4,5-с]ПИРИДИНА, ОБЛАДАЮЩИЕ ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ РЕЦЕПТОРА ГИСТАМИНА 4 (hH4R)
CA2904364A1 (en) * 2013-03-15 2014-09-25 Epigenetix, Inc. Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
AU2016356884A1 (en) * 2015-11-16 2018-06-21 Fundación Para La Investigación Médica Aplicada Novel compounds as inhibitors of dna methyltransferases
JP7212612B2 (ja) * 2016-07-28 2023-01-25 プロメガ コーポレイション セレンテラジン類縁体

Similar Documents

Publication Publication Date Title
JP6574039B2 (ja) Pi3k阻害剤としてのヘテロシクリルアミン
KR102329162B1 (ko) 카이네이즈 저해제로서의 피라졸로피리미딘 유도체
ES2704024T3 (es) Moduladores P2X7
JP2021525738A5 (https=)
AU2011267385A1 (en) Heteroaryl imidazolone derivatives as JAK inhibitors
US20200115384A1 (en) Pde9 inhibitor and use thereof
AU2015225745A1 (en) Heterocyclic compounds
RO121272B1 (ro) Azolotriazine şi pirimidine
AU2010335556A1 (en) Imidazopyridine derivatives as JAK inhibitors
KR20150135794A (ko) 6-(5-히드록시-1h-피라졸-1-일)니코틴아미드 유도체 및 phd의 저해제로서의 그의 용도
US20230192734A1 (en) Tricyclic compounds as egfr inhibitors
US7026317B2 (en) Pyrazolotriazines as CRF antagonists
JP2017534663A (ja) サーチュイン調節因子としての置換架橋尿素類似体
KR102344295B1 (ko) 헤테로사이클 유도체 및 이의 용도
AU2017265383B2 (en) Treatment of neurological disorders
CA2823935A1 (en) Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
EP3576743B1 (en) 5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2 5]octane-8-carboxylic acid derivatives as jak kinase inhibitors
HK40026045A (en) Pde9 inhibitor and use thereof
HK1241863A1 (en) Heterocyclylamines as pi3k inhibitors
HK40011502B (en) Heterocyclylamines as pi3k inhibitors
HK40011502A (en) Heterocyclylamines as pi3k inhibitors
HK1241863B (en) Heterocyclylamines as pi3k inhibitors
HK1199644B (en) Heterocyclylamines as pi3k inhibitors